In the US, Xopenex HFA (levalbuterol systemic) is a member of the drug class adrenergic bronchodilators and is used to treat Asthma, Asthma - acute, Asthma - Maintenance, COPD, COPD - Acute and COPD - Maintenance.
Ingredient matches for Xopenex HFA
Levosalbutamol tartrate (a derivative of Levosalbutamol) is reported as an ingredient of Xopenex HFA in the following countries:
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.